92
Participants
Start Date
April 30, 2008
Primary Completion Date
November 30, 2012
Study Completion Date
August 31, 2013
Cetuximab
400 mg/m2 first dose, then 250 mg/m2 weekly for 9 weeks
Docetaxel
75 mg/m2, day 1 of every 3 weeks for 9 weeks (3 cycles)
Cisplatin
75 mg/m2, day 1 of every 3 weeks for 9 weeks (3 cycles)
Seoul National University Hospital, Seoul
Collaborators (1)
Clinical Research Center for Solid Tumor, Korea
OTHER
Seoul National University Hospital
OTHER